Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria (Q34565524)

3 August 2017

1 reference

title

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria (English)

1 reference

3 August 2017

0 references

0 references

bronchiolitis obliterans

1 reference

Marc Estenne

1

1 reference

3 August 2017

Janet R Maurer

2

1 reference

3 August 2017

Annette Boehler

3

1 reference

3 August 2017

James J Egan

4

1 reference

3 August 2017

Adaani Frost

5

1 reference

3 August 2017

Marshall Hertz

6

1 reference

3 August 2017

George B Mallory

7

1 reference

3 August 2017

Gregory I Snell

8

1 reference

3 August 2017

Samuel Yousem

9

1 reference

3 August 2017

1 March 2002

1 reference

The Journal of Heart and Lung Transplantation

3 August 2017

1 reference

3 August 2017

21

1 reference

3 August 2017

3

1 reference

3 August 2017

297-310

1 reference

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Spirometry values in stable lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Pediatric lung transplantation at St. Louis Children's Hospital, 1990-1995

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Heart-lung transplantation for patients under 10 with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Intermediate-term results of heart-lung transplantation for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Forced expiratory flows and volumes in infants. Normative data and lung growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Flow limitation in infants assessed by negative expiratory pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Growth of lungs after transplantation in infants and in children younger than 3 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Treatment of presumed and proven acute rejection following six months of lung transplant survival

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Noncompliance in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Medication compliance following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Treatment of respiratory syncytial viral and parainfluenza lower respiratory tract infection in lung transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Effects of donor bone marrow infusion in clinical lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cytokine gene polymorphisms and relevance to forms of rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Importance of chronic aspiration in recipients of heart-lung transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Impaired gastrointestinal motility in pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Upper gastrointestinal dysmotility in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Risk factors for obliterative bronchiolitis in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Bordeaux Lung and Heart-Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Lymphocytic bronchitis/bronchiolitis in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Interstitial and airspace granulation tissue reactions in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Exhaled single-breath nitric oxide measurements are reproducible, repeatable and reflect levels of nitric oxide found in the lower airways

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cross sectional study of exhaled nitric oxide levels following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Exhaled Nitric Oxide in Human Lung Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. The Toronto Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Diagnosis of bronchiolitis obliterans in heart-lung transplantation patients: importance of bronchial dilatation on CT

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiectasis detected with thin-section CT as a predictor of chronic lung allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans after lung transplantation: high-resolution CT findings in 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Lung rejection and bronchial hyperresponsiveness to methacholine and ultrasonically nebulized distilled water in heart-lung transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial responsiveness after human heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Airway hyperreactivity in patients undergoing lung and heart/lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial reactivity to methacholine after combined heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial hyper-responsiveness after human cardiopulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial responsiveness to exercise after human cardiopulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial hyperresponsiveness in lung transplant recipients: lack of correlation with airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Recurrence of desquamative interstitial pneumonia after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Medium term results of lung transplantation for end stage pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Recurrence of Langerhans' cell granulomatosis following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Giant cell interstitial pneumonitis. Disease recurrence in the transplanted lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Recurrence of diffuse panbronchiolitis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Unilateral auto-PEEP in the recipient of a single lung transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Prolonged independent lung respiratory treatment after single lung transplantation in pulmonary emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Model of functional restriction in chronic obstructive pulmonary disease, transplantation, and lung reduction surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Reduced transplant lung volumes after single lung transplantation for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Volume of graft and native lung after single-lung transplantation for emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Complicated right subclavian artery pseudoaneurysm after central venipuncture

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Volume reduction of the native lung after single-lung transplantation for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Late contralateral lobectomy after single-lung transplantation for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Causes of allograft dysfunction after single lung transplantation for emphysema: extrinsic restriction versus intrinsic obstruction. Brigham and Women's Hospital Lung Transplantation Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Outcome of the native lung after single lung transplant. Multiorgan Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Morbidity and mortality related to the native lung in single lung transplantation for emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Complications in the native lung after single lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Effects of obesity and fat distribution on ventilatory function: the normative aging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Respiratory and limb muscle function in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

Cyclophosphamide rescue therapy for chronic rejection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900398-4

7 January 2021

10.1016/S1053-2498(02)00398-4

Identifiers

DOI

1 reference

3 August 2017

1 reference